Biotech MacroGenics Inc. is growing its footprint, recently leasing 122,000 square feet of wet lab space in the J. Craig Venter Institute in Rockville.
The clinical-stage biopharmaceutical company, which focuses on antibody-based therapies for cancer treatment and other diseases, will use the space for its commercial manufacturing of early clinical stage molecules, CEO Scott Koenig said.
{iframe}http://www.bizjournals.com/washington/blog/2015/08/macrogenics-begins-expansion-following-141m-round.html?ana=e_du_pap&s=article_du&ed=2015-08-14&u=wjGEy67ABoSnsLErlc5ry0j5hx3&t=1439645699{/iframe}